Open Access

Heart failure: what is the potential of SGLT2 inhibition?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Chronic heart failure
Session type: Satellite Symposium
Sponsored by AstraZeneca
Date: 1 May 2017
Time: 12:45 - 13:45

Session

6 presentations in this session

Welcome and introduction.

Speaker: Doctor S. Williams (Manchester, GB)
Speaker: Doctor J. Day (Luton, GB)
Thumbnail

The ongoing problem of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)
Thumbnail

The ongoing problem of heart failure - Q&A.

Speaker: Professor J. McMurray (Glasgow, GB)
Speaker: Doctor S. Williams (Manchester, GB)
Thumbnail

SGLT2 inhibition: the potential to change the heart failure landscape?

Speaker: Doctor M. Kosiborod (Kansas City, US)
Thumbnail

SGLT2 inhibition: the potential to change the heart failure landscape? Q&A.

Thumbnail

Summary and close.

Speaker: Doctor S. Williams (Manchester, GB)
Thumbnail

7 speakers from this session

Doctor Simon Williams

, Manchester (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

Doctor Jonathan Day

, Luton (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
82 presentations
2 followers

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
82 presentations
2 followers

Doctor Simon Williams

, Manchester (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
23 presentations
0 follower

Doctor Simon Williams

, Manchester (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk